Diagnovus has launched Engauge, a genetic test for the evaluation of non-Hodgkin lymphoma tumors. The assay can help guide personalized care and predict outcomes. The company plans to develop tests for blood cancers and childhood cancers.
Diagnovus launches tumor tissue test for non-Hodgkin lymphoma
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||